Skip to main content
. 2023 Jul 5;14:1159148. doi: 10.3389/fendo.2023.1159148

Figure 1.

Figure 1

The study design of the present MR study of the associations of gut microbiota and metabolites and liver diseases. MR, Mendelian randomization; SNP, single nucleotide polymorphism; NAFLD, non-alcoholic fatty liver disease; ALD, alcoholic liver disease; GWAS, genome-wide association study; IV, instrumental variables.